Mast Therapeutics Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Mast Therapeutics (MSTX) Reports In-Line Q1 Loss of 6c/Share
May 11, 2015 8:29 AM EDTMast Therapeutics (NYSE: MSTX) reported Q1 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.
... More